According to Kringle Pharma latest financial reports the cash on hand of 4884 is $13.81M, an decrease of -22.49% to 2022. At the end of 2022 company had $17.82M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $13.81M | -22.49% |
2022 | $17.82M | 28.95% |
2021 | $13.82M | 1.66% |
2020 | $13.59M | 1162.97% |
2019 | $1.08M | -67.05% |
2018 | $3.27M | - |